Search

everythinglearnresearchcommunity

for

Search:↓

More hair loss leads to higher risk of psychosexual disorders, especially in women.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Treat hair loss with medicine, continue indefinitely.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Smoking linked to hair loss in Asian men.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Baldness is common in Korean men (60.5%), and those with a family history are 3.1 times more likely to have hairline recession.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

Five molecular elements identified as potential future targets for hair loss therapy.

Cyclooxygenase-2 overexpression in mice skin causes hair loss like human androgenetic alopecia.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Sulfotransferase in hair follicles helps predict how well minoxidil works for female hair loss.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Scalp coverage scoring accurately measures hair loss and treatment effectiveness.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hair loss affects self-esteem and quality of life; treatments can help.